herquienone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 168617 |
| CHEMBL ID | 3799521 |
| SCHEMBL ID | 23043804 |
| MeSH ID | M0096329 |
| Synonym |
|---|
| herquienone |
| 26871-30-7 |
| herqueinone |
| (7as,9r)-4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl-9h-phenaleno[1,2-b]furan-3,7-dione |
| 3h-phenaleno(1,2-b)furan-3,7(7ah)-dione, 8,9-dihydro-4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl-, (7as-cis)- |
| unii-j0wm1vfj94 |
| j0wm1vfj94 , |
| herqueinone [mi] |
| 3h-phenaleno(1,2-b)furan-3,7(7ah)-dione, 8,9-dihydro-4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl- |
| 3h-phenaleno(1,2-b)furan-3,7(7ah)-dione, 8,9-dihydro-4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl-, (7as,9r)- |
| CHEMBL3799521 |
| Q27281003 |
| 4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl-8,9-dihydro-3h-phenaleno[1,2-b]furan-3,7(7ah)-dione |
| DTXSID70949674 |
| SCHEMBL23043804 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1295974 | Antiviral activity against Hepatitis C virus J6/JFH1 infected in human Huh7.5.1 cells assessed as reduction in amount of core HCV protein after 72 hrs by focus formation assay | 2016 | Journal of natural products, Feb-26, Volume: 79, Issue:2 | Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herquei. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||